Telaprevir Based Antiviral Triple Therapy for HCV Recurrence in Genotype-1 Infected Liver Graft Recipients.

被引：0
|
作者：
Klein, Fritz [1 ]
Neuhaus, Ruth [1 ]
Hofmann, Joerg [2 ]
Guel, Safak [1 ]
Puhl, Gero [1 ]
Neuhaus, Peter [1 ]
Bahra, Marcus [1 ]
机构：
[1] Charite Campus Virchow Univ Med Berlin, Dept Gen Visceral & Transplantat Surg, Berlin, Germany
[2] Charite Campus Mitte Univ Med Berlin, Inst Med Virol, Berlin, Germany
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [21] EXPERIENCE OF EFFECTIVE ANTIVIRAL THERAPY IN A LIVER RECIPIENT WITH RECURRENT HCV INFECTION GENOTYPE 1
    Umrik, D. V.
    Tsiroulnikova, O. M.
    Miloserdov, I. A.
    Latypov, R. A.
    Egorova, E. T.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2018, 20 (04): : 54 - 60
  • [22] HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy
    Herzer, K.
    Papadopoulos-Koehn, A.
    Timm, J.
    Paul, A.
    Jochum, C.
    Gerken, G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (36) : 1759 - 1764
  • [23] The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1
    Oze, T.
    Hiramatsu, N.
    Yakushijin, T.
    Yamada, R.
    Harada, N.
    Morishita, N.
    Oshita, M.
    Mita, E.
    Ito, T.
    Inui, Y.
    Inada, M.
    Tamura, S.
    Yoshihara, H.
    Imai, Y.
    Kato, M.
    Miyagi, T.
    Yoshida, Y.
    Tatsumi, T.
    Kasahara, A.
    Hayashi, N.
    Takehara, T.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (03) : 254 - 262
  • [24] Orexigenic ghrelin secretion in HCV-infected patients with telaprevir- or simeprevir-based triple therapy
    Aoyama, Toru
    Nagoshi, Sumiko
    Yamamoto, Ryuichi
    Yamaguchi, Naomi
    Ohno, Shino
    Yakabi, Koji
    HEPATOLOGY, 2014, 60 : 696A - 696A
  • [25] TELAPREVIR-TRIPLE THERAPY OF RECURRENT HCV GENOTYPE 1 (G1) INFECTION AFTER LIVER TRANSPLANTATION (LTX): SVR24 RESULTS
    Werner, C. R.
    Egetemeyr, D. P.
    Nadalin, S.
    Koenigsrainer, A.
    Malek, N. P.
    Lauer, U. M.
    Berg, C. P.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S375 - S375
  • [26] Genotype and choice of calcineurin inhibitor influence response to antiviral therapy in liver transplant recipients treated for recurrent HCV
    Selzner, Nazia
    Girgrah, Nigel
    Al Adawi, Ismail
    Wong, Philip
    Levy, Gary
    McQuarrie, Brenda
    Cattral, Mark
    Greig, Paul
    McGilvray, Ian
    Grant, David
    Lilly, Les
    HEPATOLOGY, 2006, 44 (04) : 481A - 481A
  • [27] Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant
    Kerstin Herzer
    Angela Papadopoulos-Khn
    Anne Achterfeld
    Ali Canbay
    Katja Piras-Straub
    Andreas Paul
    Andreas Walker
    Jrg Timm
    Guido Gerken
    World Journal of Hepatology, 2015, (09) : 1287 - 1296
  • [28] Management of telaprevir-based triple therapy for hepatitis C virus recurrence post liver transplant
    Herzer, Kerstin
    Papadopoulos-Koehn, Angela
    Achterfeld, Anne
    Canbay, Ali
    Piras-Straub, Katja
    Paul, Andreas
    Walker, Andreas
    Timm, Joerg
    Gerken, Guido
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (09) : 1287 - 1296
  • [29] TELAPREVIR-OR BOCEPREVIR-BASED TRIPLE-THERAPY IN PATIENTS WITH HCV INFECTION GENOTYPE 1: ON-TREATMENT EFFICACY AND DATA ON SAFETY
    Federico, A.
    Cotticelli, G.
    De Simini, G.
    Gravina, A. G.
    Miranda, A.
    Sgambato, D.
    Dallio, M.
    De Sio, C.
    Ferrante, E.
    Meucci, R.
    Rossetti, G.
    Vitale, L. M.
    Beneduce, F.
    Romano, M.
    Loguercio, C.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S123 - S123
  • [30] Protease inhibitor-based triple therapy is highly effective in liver transplant recipients with genotype 1 hepatitis C recurrence: A Canadian multicentre experience
    Faisal, Nabiha
    Renner, Eberhard L.
    Bilodeau, Marc
    Yoshida, Eric M.
    Wong, Philip
    Ma, Mang M.
    Burak, Kelly W.
    Al-Judaibi, Bandar
    Cooper, Curtis
    Shaw-Stiffel, Thomas
    Lilly, Les
    HEPATOLOGY, 2013, 58 : 238A - 238A
12345